Quick Answer
ASPEN AEROGELS INC reported Research And Development Expense of $13.42 million for the year ending 2025.
- ASPEN AEROGELS INC showed a decrease of -25.7% in Research And Development Expense from 2024 to 2025.
- This data is from ASPEN AEROGELS INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), ASPEN AEROGELS INC's Research And Development Expense has grown by 160.9%.
- Historical annual values: Fiscal year 2025: $13.42 million | Fiscal year 2024: $18.05 million | Fiscal year 2023: $16.36 million | Fiscal year 2022: $16.93 million | Fiscal year 2021: $11.44 million | Fiscal year 2020: $8.73 million | Fiscal year 2019: $8.41 million | Fiscal year 2018: $6.32 million | Fiscal year 2017: $6.18 million | Fiscal year 2016: $5.31 million | Fiscal year 2015: $5.25 million | Fiscal year 2014: $5.98 million | Fiscal year 2013: $5.16 million | Fiscal year 2012: $5.14 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: